PharmaEssentia Corporation (TPE:6446)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
536.00
+6.00 (1.13%)
Apr 2, 2025, 1:30 PM CST

PharmaEssentia Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
178,511204,725114,578143,84078,06524,709
Upgrade
Market Cap Growth
78.68%78.68%-20.34%84.26%215.94%2.44%
Upgrade
Enterprise Value
158,425184,91594,836140,32277,60321,027
Upgrade
Last Close Price
536.00615.00346.00477.00289.3492.63
Upgrade
PE Ratio
60.3669.04----
Upgrade
Forward PE
35.1341.3631.8969.03--
Upgrade
PS Ratio
18.2321.0322.4449.91118.9144.34
Upgrade
PB Ratio
6.507.454.7811.8518.376.30
Upgrade
P/TBV Ratio
7.537.534.8412.0819.506.68
Upgrade
P/FCF Ratio
121.51121.51----
Upgrade
P/OCF Ratio
80.3880.38----
Upgrade
EV/Sales Ratio
16.2719.0018.5848.69118.2137.73
Upgrade
EV/EBITDA Ratio
76.42100.14----
Upgrade
EV/EBIT Ratio
91.25106.51----
Upgrade
EV/FCF Ratio
94.03109.75----
Upgrade
Debt / Equity Ratio
0.040.040.050.130.130.17
Upgrade
Debt / EBITDA Ratio
0.470.47----
Upgrade
Debt / FCF Ratio
0.570.57----
Upgrade
Asset Turnover
0.330.330.240.270.110.13
Upgrade
Inventory Turnover
0.860.860.480.830.601.15
Upgrade
Quick Ratio
9.349.349.864.372.803.37
Upgrade
Current Ratio
9.949.9410.645.243.493.82
Upgrade
Return on Equity (ROE)
11.54%11.54%-3.46%-16.77%-68.81%-63.10%
Upgrade
Return on Assets (ROA)
3.72%3.72%-5.61%-11.77%-30.08%-25.26%
Upgrade
Return on Capital (ROIC)
4.05%4.05%-6.16%-13.71%-37.72%-29.60%
Upgrade
Return on Capital Employed (ROCE)
6.10%6.10%----
Upgrade
Earnings Yield
1.66%1.45%-0.54%-0.96%-3.60%-7.88%
Upgrade
FCF Yield
0.94%0.82%-1.74%-1.26%-3.24%-6.22%
Upgrade
Dividend Yield
0.21%0.18%----
Upgrade
Buyback Yield / Dilution
-3.59%-3.59%-13.47%-9.24%-7.39%-10.55%
Upgrade
Total Shareholder Return
-3.38%-3.41%-13.47%-9.24%-7.39%-10.55%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.